Ligand Pharmaceuticals Inc. (LGND)
NASDAQ · Healthcare
Ligand Pharmaceuticals Inc. Cash Flow 2009–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||||
| Operating Cash Flow | 49.4M | 97.0M | 49.6M | 137.8M | 78.8M | 54.6M | -29.3M | 194.1M | 88.6M | 60.7M | 41.7M | 20.6M | 20.7M | 161,000 | -1.2M | -27.1M | -33.8M |
| Depreciation & Amort. | 33.8M | 35.2M | 36.5M | 51.5M | 51.1M | 25.7M | 18.4M | 12.8M | 11.0M | 11.3M | 2.6M | 2.7M | 2.7M | 2.7M | 2.8M | 2.2M | 4.6M |
| Investing Activities | |||||||||||||||||
| Capital Expenditure | 452,000 | 1.8M | 3.5M | 17.9M | 8.8M | 4.5M | 2.6M | 887,000 | 2.2M | 1.9M | 93,000 | 6,000 | 377,000 | 595,000 | 78,000 | 70,000 | 522,000 |
| Free Cash Flow | 48.9M | 95.2M | 46.1M | 119.9M | 70.0M | 50.1M | -31.9M | 193.2M | 86.4M | 58.9M | 41.6M | 20.6M | 20.3M | -434,000 | -1.3M | -27.1M | -34.3M |
| Financing Activities | |||||||||||||||||
| Dividends Paid | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock Buybacks | 15.0M | 0 | 0 | 0 | 0 | 78.0M | 453.0M | 122.9M | 2.0M | 3.9M | 489,000 | 68.0M | 0 | 0 | 55,000 | 91,000 | — |
Ligand Pharmaceuticals Inc. Cash Flow — FAQ
Ligand Pharmaceuticals Inc. (LGND) cash flow over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see LGND's cash flow history?
The chart and table above show Ligand Pharmaceuticals Inc.'s cash flow by year and by quarter, including the growth rate.